Cargando…
Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis. Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells. Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistanc...
Autores principales: | Williams, Michelle M., Cook, Rebecca S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414133/ https://www.ncbi.nlm.nih.gov/pubmed/25784482 |
Ejemplares similares
-
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
por: Rooswinkel, R W, et al.
Publicado: (2012) -
Overcoming MCL-1-driven adaptive resistance to targeted therapies
por: Wood, Kris C.
Publicado: (2020) -
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
por: Kapoor, Isha, et al.
Publicado: (2020) -
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019) -
Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers
por: Williams, Michelle M., et al.
Publicado: (2019)